The World Health Organization (WHO) announced on Monday their recommendation for the use of GLP-1 drugs as a tool to manage obesity in adults.
“Obesity is a major global health challenge that WHO is committed to addressing by supporting countries and people worldwide to control it, effectively and equitably,” WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a press release. “Our new guidance recognizes that obesity is a chronic disease that can be treated with comprehensive and lifelong care.”
The organization also emphasized that GLP-1 drugs should be part of a long-term treatment strategy.
This approach would require combining medication with counseling on healthy diets and physical activity, said WHO.
To read the full recommendation, visit the WHO website.
